Three stable free radicals have been prepared which are akin to 5-aziridino-2,4-dinitrobenzamide (CB 1954) ; these compounds all contain a nitroxide function. The metabolism and excretion of two such compounds in mice has been moni tored by electron spin resonance (E S R ) spectroscopy and compared with that of the simpler nitioxide, 4-keto-2,2,6,6-tetramethylpiperidino-l-oxyl (tempone).
The ESR technique has been used extensively 1 in efforts to elucidate the role of free radicals in car cinogenesis although results obtained are notorious ly difficult to interpret. Recently Sosnovski et al. 2 described the synthesis of spin-labelled analogues 1 of the antineoplastic drugs3 TEPA (2 a) and thio TEPA (2 b ). They believe2 that compounds of this type could be useful for two reasons: first, they may exhibit scavenging properties on free radicals and/or other paramagnetic species in tumour tissues; and secondly the mode of such interactions might be amenable to investigation by ESR spectroscopy. It is also of interest that certain nitroxides have been shown to act as radiation sensitizers in vitro 4 and in v ivo 5 . In this paper we describe our results on the synthesis of spin-labelled nitroarylaziridine analogues (3a -c; see scheme) and our attempts to monitor their activity by ESR spectroscopy both in vitro and in vivo. We also report related ESR studies using the readily available 6 4-keto-2,2,6,6-tetramethylpiperidino-l-oxyl (tempone).
The new compounds 3a -c arc analogues of 5-aziridino-2,4-dinitrobenzamide' (C B 1954) (3 d ) which exhibits7 potent tumour-groivth inhibitory activity against Walker carcinoma 256. The free radicals labelled at the amido group (3a, b ) were prepared by nucleophilic displacement of chloride ion from 3e by aziridine and piperidine respec tively; the chloride 3e was synthesised by reaction of the known 8 aroyl halide 3f with 4-amino-2,2,6,6-tetramethylpiperidino-l-oxyl in tetrahydrofuran at -46 °C. A nucleophilic displacement was also em ployed to synthesise the nitroxide 3c from the halide 3g.
E S R results
ESR spectra were recorded using a Varian E-9 spectrometer. The spectra of aqueous solutions of the spin labels 3a and 3c were indistinguishable, showing three lines with a$ = 1.71 + 0.02 mT and g0 = 2.0063 ± 0.0003. Their solubility in water is of the order of 5 x lO -6M . Therefore 2.5 mg of label was dissolved in DMSO and diluted with 9 volumes of arachis oil 7. This suspension (0.25 ml) was injected intraperitoneally into each of a number of 4 month old female RFM/Un mice. The spin labels could not be detected, by ESR, in the blood, liver or kidney, even within 10 min of injection. In one case, sacrifice of a mouse 10 min after an intra venous injection of label 3c in DMSO also failed to reveal any signal in the blood. However, urine samples taken between 30 min and 4.5 h after in jection showed the presence of a signal indistin guishable from that of the injected spin label and representing a concentration of 10~5 -10~6M.
Further experiments were carried out using the water soluble spin label tempone. 0.2 ml of a 5 x 10~3m solution of tempone in physiological saline was injected into each mouse. In this case a three line spectrum was detected in the blood, 10 min after injection, representing a concentration of about 10" " M. The concentration fell by approximately 50% within 1 h and was no longer detectable after 4 h. An identical, but more intense, signal was de tected in the urine. This decreased in concentration from about 10_4M , l h after injection, to 10-6 M, 4h after injection. The signal had a g-value of 2.0 0 6 4 ±0.0003 and aN -= 1.71 ± 0.02 mT. This differs from the signal in water, w'hich was found to have = 1.61 ± 0.02 mT and g0 = 2.0063 + 0.0003. Addition of tempone to whole blood, plasma or urine in vitro gave a signal with a^= 1.61 mT.
Consequently the species present in the blood and urine of tempone injected mice is not tempone. Further studies showed that the signal from tem pone added to whole blood or plasma was barely detectable after 3 h storage on ice. In contrast, storage at 0 °C or room temperature, of blood from injected animals produced an increase in the ESR signal.
It can be concluded that tempone is rapidly meta bolized in mice, following intraperitoneal injection. One possible reaction is conversion of the keto group to hydroxyl and subsequent formation of a glucuronide9, but this suggestion is tentative until we complete our studies using simple spin labels containing a variety of functional groups. The in crease in signal with time in vitro suggests that tempone or its metabolite complexes reversibly in vivo with some component of blood, thereby broadening the ESR signal beyond detection. The reduction of several drugs is known9 to involve the oxidation of haemoglobin and we attempted to monitor such an interaction. However, low tem perature ESR examination of blood from mice in jected with tempone or the label 3c failed to show the presence of a complex of haemoglobin and the nitroxide and showed that there was no increase in methaemoglobin.
The absence of a detectable signal in blood of animals injected with the spin labels 3a and 3c is probably due to the low solubility of the labels in aqueous media and to the formation of a complex in blood, which lowers, still further, the concentra tion of free label or its metabolite.
The preliminary experiments reported here in dicate the potential value of the ESR technique in determining the fate of spin-labelled drugs in vivo. This is of considerable importance since the metabo lism and binding of spin labels will affect their pos sible anti-tumour activity or radiosensitizing action.
Antitumour evaluation
The nitroxides 3a and c were evaluated for effect on Walker tumour cells in vitro, a system in which CB 1954 3d kills 99% of tumour cells at a con centration of 1 //g-ml_1. Compound 3a was effec tive (99% tumour cell kill) only at lOO/zg'ml^1 while 3c had no effect even at 100 //g-ml-1.
Experimental
4-Keto-2,2,6,6-tetramethylpiperidino-l-oxyl (tem pone) was prepared by a reported6 procedure. 4-Amino-2,2,6,6-tetramethylpiperidino-l-oxyl was purchased from Aldrich Chemical Co. and used without further purification.
-C h l o r o -N -[ 4-(2 ,2 ,6,6-tetramethylpiperidino-lo x y l )] -2,4-dinitrobenzamide (3 e)
4-Amino-2,2,6,6-tetramethylpiperidino-l-oxyl (1.0 g, 5.9 mmol) and triethylamine (0.5 g) in dry tetrahydrofuran (15 ml) was added dropwise with stir ring to a solution of 5-chloro-2,4-dinitrobenzoyl chloride (1.5 g, 5.8 mmol) and triethylamine (0.35 g) in tetrahydrofuran (10 ml) at -46°. After 4.5 h the mixture was warmed to room tem perature and the product was filtered. The filtrate was evaporated to leave a red oil which was purified chromatographically ( silica gel, 3:1, benzene : chloroform eluant). This material was recrystallised from chloroform/hexane to give 3e as yellow need les (0.9 g, 34%), m.p. 23 0 -2 3 1 °C, / f f i H 229 nm (sh), 252 (e, 12,600), M+ found 399.1061; req. 399.1072. Found: C, 48.01; H, 5.11; N, 13.86%. C16H20N4O6Cl requires: C, 48.07; H, 5.04; N, 14.01%. 
